Details for New Drug Application (NDA): 209128
✉ Email this page to a colleague
NDA 209128 describes DSUVIA, which is a drug marketed by Vertical Pharms and is included in one NDA. There are twenty-one patents protecting this drug. Additional details are available on the DSUVIA profile page.
The generic ingredient in DSUVIA is sufentanil citrate. There are nine drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the sufentanil citrate profile page.
The generic ingredient in DSUVIA is sufentanil citrate. There are nine drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the sufentanil citrate profile page.
Summary for 209128
| Tradename: | DSUVIA |
| Applicant: | Vertical Pharms |
| Ingredient: | sufentanil citrate |
| Patents: | 21 |
Medical Subject Heading (MeSH) Categories for 209128
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;SUBLINGUAL | Strength | EQ 0.03MG BASE | ||||
| Approval Date: | Nov 2, 2018 | TE: | RLD: | Yes | |||||
| Patent: | ⤷ Start Trial | Patent Expiration: | Jan 5, 2027 | Product Flag? | Y | Substance Flag? | Delist Request? | ||
| Patented Use: | TREATMENT OF ACUTE PAIN | ||||||||
| Patent: | ⤷ Start Trial | Patent Expiration: | Jan 5, 2027 | Product Flag? | Y | Substance Flag? | Delist Request? | ||
| Patent: | ⤷ Start Trial | Patent Expiration: | Jan 5, 2027 | Product Flag? | Y | Substance Flag? | Delist Request? | ||
| Patented Use: | TREATMENT OF ACUTE PAIN | ||||||||
Complete Access Available with Subscription
